Hopwood J J, Elliott H
Carbohydr Res. 1981 May 1;91(2):165-90. doi: 10.1016/s0008-6215(00)86029-2.
Heparin was carboxyl-reduced with NaBT4, and degraded under conditions of acid hydrolysis that selectively cleaved the 2-0-sulfo-L-idopyranosidic linkages. The resulting, radiolabelled-disaccharides and -tetrasaccharides were isolated by gel chromatography, and then fractionated by ion-exchange chromatography, paper chromatography, and paper electrophoresis. Of the nine disaccharides isolated and identified, eight were probably derived from the major repeating-disaccharide unit in heparin (2-deoxy-2-sulfoamino-D-glucosyl 6-sulfate leads to L-idosyluronic acid 2-sulfate). Sodium borotritide reduction and/or HNO2 deamination of these eight disaccharide fractions indicated four to contain L-idopyranose residues and the other four to contain 1,6-anhydro-L-idopyranose residues as terminal units. The latter, terminal unit probably represents a minor component formed during the acid hydrolysis. On the basis of N-acetylation, N-sulfation, and HNO2-deamination studies, and the known positions and configurations of the glycosidic and sulfate linkages in heparin, four disaccharides were identified as 0-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-(1 leads to 4)-L-[6-3H]idopyranose, 0-(2-amino-2-deoxy-alpha-D-glycopyranosyl)-(1 leads to 4)-L-[6-3H]idopyranose 2-sulfate, and 0-(2-amino-2-deoxy-alpha-D-glucopyranosyl 6-sulfate]-(1 leads to 4)-L-[6-3H]idopyranose 2-sulfate. A similar set of four disaccharides contained 1,6-anhydro-L-[6-3H]idopyranose residues in place of the L-[6-3H]idopyranose residues. The other disaccharide was tentatively identified as 0-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl)-(1 leads to 4)-L-[6-3H]idopyranose, the isolation of which suggests the presence of an IdA(OSO-3)-GlcNAc-IdA(OSO-3) sequence in the heparin preparation, which accounts for at least 1% of its total sequence. The tetrasaccharides were fractionated, on the basis of their sulfate content, into at least five species by ion-exchange chromatography or by paper electrophoresis. These were fractionated further into species with and without carboxyl groups, and with L-idopyranose or 1,6-anhydro-L-idopyranose residues as terminal units. Tentative structures for some of these tetrasaccharides are proposed. Disaccharide and tetrasaccharide species were evaluated before and after N-acetylation or N-sulfation, as substrates for sulfamidase, acetyl-CoA: 2-amino-2-deoxy-alpha-D-glucoside N-acetyl-transferase, 2-acetamido-2-deoxy-alpha-D-glucosidase, or 2-acetamido-2-deoxy-D-glucose 6-sulfate sulfatase in human-skin fibroblasts.
用NaBT4对肝素进行羧基还原,并在酸性水解条件下进行降解,该条件可选择性地切断2-O-磺基-L-艾杜吡喃糖苷键。通过凝胶色谱法分离得到放射性标记的二糖和四糖,然后通过离子交换色谱法、纸色谱法和纸电泳法进行分级分离。在分离和鉴定的9种二糖中,8种可能来源于肝素中的主要重复二糖单元(2-脱氧-2-磺氨基-D-葡糖基6-硫酸盐连接到L-艾杜糖醛酸2-硫酸盐)。对这8个二糖级分进行硼氢化三氚钠还原和/或亚硝酸脱氨表明,其中4个含有L-艾杜吡喃糖残基,另外4个含有1,6-脱水-L-艾杜吡喃糖残基作为末端单元。后者的末端单元可能代表酸性水解过程中形成的次要成分。基于N-乙酰化、N-硫酸化和亚硝酸脱氨研究,以及肝素中糖苷键和硫酸酯键的已知位置和构型,鉴定出4种二糖为O-(2-氨基-2-脱氧-α-D-葡糖吡喃糖基)-(1→4)-L-[6-3H]艾杜吡喃糖、O-(2-氨基-2-脱氧-α-D-葡糖吡喃糖基)-(1→4)-L-[6-3H]艾杜吡喃糖2-硫酸盐和O-(2-氨基-2-脱氧-α-D-葡糖基6-硫酸盐)-(1→4)-L-[6-3H]艾杜吡喃糖2-硫酸盐。类似的一组4种二糖含有1,6-脱水-L-[6-3H]艾杜吡喃糖残基代替L-[6-3H]艾杜吡喃糖残基。另一种二糖暂定为O-(2-乙酰氨基-2-脱氧-α-D-葡糖吡喃糖基)-(1→4)-L-[6-3H]艾杜吡喃糖,其分离表明肝素制剂中存在IdA(OSO-3)-GlcNAc-IdA(OSO-3)序列,该序列至少占其总序列的1%。根据四糖的硫酸盐含量,通过离子交换色谱法或纸电泳法将其至少分为5种。这些进一步分为带有和不带有羧基的种类,以及以L-艾杜吡喃糖或1,6-脱水-L-艾杜吡喃糖残基作为末端单元的种类。提出了其中一些四糖的暂定结构。在人皮肤成纤维细胞中,对二糖和四糖种类在N-乙酰化或N-硫酸化前后作为硫酸酰胺酶、乙酰辅酶A:2-氨基-2-脱氧-α-D-葡糖苷N-乙酰转移酶、2-乙酰氨基-2-脱氧-α-D-葡糖苷酶或2-乙酰氨基-2-脱氧-D-葡萄糖6-硫酸盐硫酸酯酶的底物进行了评估。